Designating November 2025 as American Diabetes Month.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Designates November 2025 as American Diabetes Month and expresses Senate support for awareness, prevention, treatment, research, and improved access to care.
Who Benefits and How
People affected by diabetes and advocacy communities receive a formal Senate statement supporting awareness, prevention, research, and access to care.
Who Bears the Burden and How
The resolution is nonbinding and mainly serves an awareness and recognition function rather than imposing legal obligations.
Key Provisions
- Designates November 2025 as American Diabetes Month.
- Supports public awareness, education, prevention, and treatment efforts.
- Highlights research and access-to-care priorities through a Senate resolution.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Designates November 2025 as American Diabetes Month and expresses Senate support for awareness, prevention, treatment, research, and improved access to care.
Key Policy Areas
Healthcare, Government Operations
Primary Purpose
Designates November 2025 as American Diabetes Month and expresses Senate support for awareness, prevention, treatment, research, and improved access to care.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- People living with diabetes or at risk of diabetes
- Healthcare and advocacy groups focused on diabetes awareness
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- No direct regulated parties because the resolution is nonbinding
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
Mrs. Shaheen (for herself and Ms. Collins) submitted the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology